Clinical Trial Update: The Effect of Tranexamic Acid on Blood Loss and Transfusion Requirements Following Open Femur Fracture Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial investigating tranexamic acid to reduce blood loss and transfusion needs after open femur fracture surgery; study status: withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open Femur Fracture

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Blood Loss Following Open Femur Fracture Surgery | Phase 4 | Status: WITHDRAWN